Literature DB >> 17325276

Variations in the APP gene promoter region and risk of Alzheimer disease.

L Guyant-Maréchal1, A Rovelet-Lecrux, L Goumidi, E Cousin, D Hannequin, G Raux, C Penet, S Ricard, S Macé, P Amouyel, J-F Deleuze, T Frebourg, A Brice, J-C Lambert, D Campion.   

Abstract

We genotyped five polymorphisms, including two polymorphisms with known effects on transcriptional activity, in a large cohort of 427 Alzheimer disease (AD) cases and 472 control subjects. An association between rs463946 (-3102 G/C) and AD was found and was confirmed in a replication sample of a similar size. By contrast, analysis of three recently described rare mutations influencing APP transcription did not confirm their association with AD risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325276     DOI: 10.1212/01.wnl.0000255938.33739.46

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

2.  Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.

Authors:  L M Bekris; N M Galloway; S Millard; D Lockhart; G Li; D R Galasko; M R Farlow; C M Clark; J F Quinn; J A Kaye; G D Schellenberg; J B Leverenz; P Seubert; D W Tsuang; E R Peskind; C E Yu
Journal:  Neurobiol Aging       Date:  2010-12-31       Impact factor: 4.673

3.  Amyloid precursor protein gene (APP) variation in late-onset Alzheimer's disease.

Authors:  Ana Miar; Victoria Alvarez; Ana I Corao; Marta Díaz; Belén Alonso; Carmen Martínez; María T Calatayud; Manuel Menéndez; Germán Morís; Eliecer Coto
Journal:  J Mol Neurosci       Date:  2011-03-22       Impact factor: 3.444

4.  Genetic susceptibility for Alzheimer disease neuritic plaque pathology.

Authors:  Joshua M Shulman; Kewei Chen; Brendan T Keenan; Lori B Chibnik; Adam Fleisher; Pradeep Thiyyagura; Auttawut Roontiva; Cristin McCabe; Nikolaos A Patsopoulos; Jason J Corneveaux; Lei Yu; Matthew J Huentelman; Denis A Evans; Julie A Schneider; Eric M Reiman; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

Review 5.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

6.  Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy.

Authors:  Gaël Nicolas; David Wallon; Claudia Goupil; Anne-Claire Richard; Cyril Pottier; Véronique Dorval; Mariana Sarov-Rivière; Florence Riant; Dominique Hervé; Philippe Amouyel; Maelenn Guerchet; Bebene Ndamba-Bandzouzi; Pascal Mbelesso; Jean-François Dartigues; Jean-Charles Lambert; Pierre-Marie Preux; Thierry Frebourg; Dominique Campion; Didier Hannequin; Elisabeth Tournier-Lasserve; Sébastien S Hébert; Anne Rovelet-Lecrux
Journal:  Eur J Hum Genet       Date:  2015-04-01       Impact factor: 4.246

7.  Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.

Authors:  Thomas van Groen; Inga Kadish; Susanne Aileen Funke; Dirk Bartnik; Dieter Willbold
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Regulation of amyloid precursor protein processing by the Beclin 1 complex.

Authors:  Philipp A Jaeger; Fiona Pickford; Chung-Huan Sun; Kurt M Lucin; Eliezer Masliah; Tony Wyss-Coray
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

Review 9.  Current status on Alzheimer disease molecular genetics: from past, to present, to future.

Authors:  Karolien Bettens; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2010-04-13       Impact factor: 6.150

Review 10.  Recent insights into the molecular genetics of dementia.

Authors:  Rosa Rademakers; Anne Rovelet-Lecrux
Journal:  Trends Neurosci       Date:  2009-07-27       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.